A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B

Alimentary Pharmacology&Therapeutics, EarlyView.

Source: Alimentary Pharmacology and Therapeutics - July 2, 2018 Category: Drugs & Pharmacology Authors: R. El Sharkawy , K. Thabet , P. Lampertico , S. Petta , A. Mangia , T. Berg , M. Metwally , A. Bayoumi , A. Boonstra , W. P. Brouwer , A. Smedile , M. L. Abate , A. Loglio , M. W. Douglas , A. Khan , R. Santoro , J. Fisc Source Type: research